The latest genomic analysis of pancreatic tumors identified two new pathways involved in the disease, information that could be capitalized on to develop new and earlier diagnostic tests for the disease, said a Baylor College of Medicine physician-scientist who was part of the local team that took part in the international effort. Read more here.
Study mentioned: Biankin AV, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012 Oct 24. [Epub ahead of print] PMID: 23103869
No comments:
Post a Comment